Cargando…

The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction

BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) constitutes a global health issue. While proinflammatory cytokines proved to have a pivotal role in the development and progression of HFrEF, less attention has been paid to the cellular immunity. Regulatory T lymphocytes (Tregs) seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammer, Andreas, Sulzgruber, Patrick, Koller, Lorenz, Kazem, Niema, Hofer, Felix, Richter, Bernhard, Blum, Steffen, Hülsmann, Martin, Wojta, Johann, Niessner, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035577/ https://www.ncbi.nlm.nih.gov/pubmed/32104149 http://dx.doi.org/10.1155/2020/6079713

Ejemplares similares

The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome
por: Kazem, Niema, et al.
Publicado: (2021)

Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Steinacher, Eva, et al.
Publicado: (2022)

Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
por: Hofer, Felix, et al.
Publicado: (2023)

Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?
por: Hammer, Andreas, et al.
Publicado: (2023)

Expert Opinion: Meditation and Cardiovascular Health: What is the Link?
por: Schnaubelt, Sebastian, et al.
Publicado: (2019)

Propensity for Calcification in Serum Associates With 2-Year Cardiovascular Mortality in Ischemic Heart Failure With Reduced Ejection Fraction
por: Bojic, Marija, et al.
Publicado: (2021)

The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies
por: Hofer, Felix, et al.
Publicado: (2021)

Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure
por: Schrutka, Lore, et al.
Publicado: (2016)

The impact of volume substitution on post‐operative atrial fibrillation
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

The Impact of Preclinical High Potent P2Y(12) Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome
por: Hammer, Andreas, et al.
Publicado: (2023)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

An increase in acute heart failure offsets the reduction in acute coronary syndrome during coronavirus disease 2019 (COVID‐19) outbreak
por: Sulzgruber, Patrick, et al.
Publicado: (2020)

Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis
por: Winter, Max-Paul, et al.
Publicado: (2018)

Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome
por: Sulzgruber, Patrick, et al.
Publicado: (2015)

The impact of CD4(+)CD28(null) T lymphocytes on atrial fibrillation: a potential pathophysiological pathway
por: Hammer, Andreas, et al.
Publicado: (2021)

CD4(+)CD28(null) T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery
por: Sulzgruber, Patrick, et al.
Publicado: (2018)

An Extended Duration of the Pre-Operative Hospitalization is Associated with an Increased Risk of Healthcare-Associated Infections after Cardiac Surgery
por: Sulzgruber, Patrick, et al.
Publicado: (2020)

De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction
por: Steininger, Matthias, et al.
Publicado: (2018)

The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report
por: Hammer, Andreas, et al.
Publicado: (2020)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

The Role of Ejection Fraction to Clinical Outcome of Acute Ischemic Stroke Patients
por: Rahmayani, Fidha, et al.
Publicado: (2018)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Sex differences in circulating proteins in heart failure with preserved ejection fraction
por: Stienen, Susan, et al.
Publicado: (2020)

Heart Failure With Reduced Ejection Fraction Is Characterized by Systemic NEP Downregulation
por: Pavo, Imre J., et al.
Publicado: (2020)

New Cardiovascular Biomarkers in Ischemic Heart Disease—GDF-15, A Probable Predictor for Ejection Fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Assessing cardiac function in the single ventricle circulation: Kinetic energy ejection fraction
por: Wong, James, et al.
Publicado: (2015)

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
por: Schäfer, Andreas, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
por: Haller, Paul M., et al.
Publicado: (2020)

Pressure‐based estimation of right ventricular ejection fraction
por: Heerdt, Paul M., et al.
Publicado: (2022)

N8‐Acetylspermidine: A Polyamine Biomarker in Ischemic Cardiomyopathy With Reduced Ejection Fraction
por: Nayak, Aditi, et al.
Publicado: (2020)

Association Between Myocardial Scar Burden and Left Ventricular Ejection Fraction in Ischemic Cardiomyopathy
por: Aboul Enein, Fatma, et al.
Publicado: (2020)

Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction
por: Cuvelliez, Marie, et al.
Publicado: (2019)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction
por: Marzluf, Beatrice A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5t2mn56k7qfuhkp1n9gsr92do7